[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:renal-cell-carcinoma:programmed-cell-death-protein-1":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Renal Cell Carcinoma","Programmed Cell Death Protein 1",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04895709","A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:19:00.742020Z","2026-06-16T05:54:07.907527Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06425926","Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors",[12],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:27.481608Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06741644","A Phase I\u002FII Study of CS2009 in Participants With Advanced Solid Tumors",[12],"2026-08-26T02:17:28.381459Z","2026-07-19T19:36:05.136448Z"]